Загрузка...
Improving the Safety of Medicines in the European Union: From Signals to Action
Pharmacovigilance and risk minimization must be planned during drug development and forms a critical part of the regulator's decision on whether a medicinal product can be authorized. Pharmacovigilance systems should ensure proactive monitoring of all authorized medicines throughout their lifec...
Сохранить в:
| Опубликовано в: : | Clin Pharmacol Ther |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7027976/ https://ncbi.nlm.nih.gov/pubmed/31621897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1678 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|